COEP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: no Intellectia buy signals, weak/indecisive technical setup, and pattern-based odds favor further downside over the next day/week/month.", "Current price (13.5) is below the pivot (14.087), suggesting the stock is trading under a key near-term balance point with overhead resistance.", "With no news catalysts and still-lossmaking financials, there\u2019s no clear near-term trigger to justify an impatient entry."]
["Trend/structure: Price 13.5 is below Pivot 14.087 and above S1 12.782; this places COEP in a vulnerable zone where a break of 12.782 can accelerate downside, while rebounds face resistance near 14.087 then 15.391.", "MACD: Histogram is positive (0.0797) but contracting, implying bullish momentum is fading rather than strengthening.", "RSI(6): 48.381 (neutral), confirming lack of strong buying pressure.", "Moving averages: Converging MAs indicate consolidation/chop rather than a clean uptrend.", "Quant/pattern read: Similar candlestick-pattern analysis suggests a 60% chance of -0.48% next day, -0.95% next week, and -3.97% next month (tilts bearish).", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Net loss improved YoY in 2025/Q3 (loss narrowed by ~58%).", "MACD remains above zero, indicating residual positive momentum despite weakening."]
with nearby support at 12.782; technicals do not show strong demand.", "Pattern-based forward return expectation is negative across 1-day/1-week/1-month horizons.", "EPS worsened YoY (2025/Q3 EPS -0.58, down 33.33% YoY) and gross margin is negative, reinforcing weak operating quality."]
["Latest reported quarter: 2025/Q3.", "Revenue: 237,441, essentially flat YoY (0.00% YoY), indicating limited top-line momentum.", "Net income: -2,739,403 (still a loss) but improved YoY (~+58.11% improvement).", "EPS: -0.58, worse YoY (-33.33%), implying per-share profitability deteriorated despite the net loss improvement.", "Gross margin: negative (-24.31), suggesting the business is not currently operating with healthy unit economics."]
["No analyst rating or price target change data was provided, so there\u2019s no visible recent Wall Street consensus shift to support a buy thesis.", "Wall Street pros/cons view (based on available data only): Pros\u2014loss narrowing YoY; Cons\u2014flat revenue, negative margins, worsening EPS, and no near-term catalyst."]
